Literature DB >> 10566647

Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases.

Y Kitamura1, K Shimizu, M Nagahama, K Sugino, O Ozaki, T Mimura, K Ito, K Ito, S Tanaka.   

Abstract

Most patients with thyroid carcinoma have a good prognosis. Due to the small number of fatal cases, it has not been clarified what conditions result in death for patients with thyroid carcinoma. To provide appropriate management for advanced thyroid carcinoma patients, we analyzed causes of death in 161 fatal cases. Clinical characteristics and immediate (final) causes of death based on pathological conditions were analyzed in 62 anaplastic carcinomas and 99 fatal differentiated carcinomas. Single fatal conditions could not be specified in 55 patients. In the remaining 106 patients, respiratory insufficiency (43%) was the most common specific fatal condition, followed by circulatory failure (15%), hemorrhage (15%), and airway obstruction (13%). Respiratory insufficiency due to remarkable pulmonary metastasis replacing lung tissue, massive hemorrhage and airway obstruction due to uncontrolled local tumors, and circulatory failure resulting from compression of the vena cava by extensive mediastinal or sternal metastases were found to be the most important immediate causes of death. Based on this knowledge, several palliative procedures may be worth considering to improve survival and quality of life in patients with advanced thyroid carcinoma.

Entities:  

Mesh:

Year:  1999        PMID: 10566647     DOI: 10.1210/jcem.84.11.6115

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  61 in total

1.  Metastatic papillary thyroid carcinoma and severe airflow obstruction.

Authors:  Christopher Manganaris; Steven Wittlin; Haodong Xu; Michael Gurell; Patricia Sime; Robert Matthew Kottmann
Journal:  Chest       Date:  2010-09       Impact factor: 9.410

2.  Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients.

Authors:  Iwao Sugitani; Akira Miyauchi; Kiminori Sugino; Takahiro Okamoto; Akira Yoshida; Shinichi Suzuki
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

Review 3.  Papillary thyroid cancer: medical management and follow-up.

Authors:  Richard T Kloos
Journal:  Curr Treat Options Oncol       Date:  2005-07

4.  Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinicopathologic and Molecular Characteristics.

Authors:  Bin Xu; R Michael Tuttle; Mona M Sabra; Ian Ganly; Ronald Ghossein
Journal:  Thyroid       Date:  2017-02-01       Impact factor: 6.568

5.  Segmental tracheal resection for invasive differentiated thyroid carcinoma. Our experience in eight cases.

Authors:  Claudio Mossetti; Nicola Palestini; Maria Cristina Bruna; Michele Camandona; Milena Freddi; Alberto Oliaro; Guido Gasparri
Journal:  Langenbecks Arch Surg       Date:  2013-12       Impact factor: 3.445

6.  Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer.

Authors:  Carlos A Benbassat; Sara Mechlis-Frish; Dania Hirsch
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

7.  Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo.

Authors:  Xiao-Min Yu; TramAnh Phan; Priyesh N Patel; Renata Jaskula-Sztul; Herbert Chen
Journal:  Cancer       Date:  2012-09-18       Impact factor: 6.860

8.  Follicular adenoma and carcinoma of the thyroid gland.

Authors:  Christopher R McHenry; Roy Phitayakorn
Journal:  Oncologist       Date:  2011-04-11

9.  Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis?

Authors:  Elif Hindié; Didier Mellière; Françoise Lange; Iyad Hallaj; Claire de Labriolle-Vaylet; Christian Jeanguillaume; Jacques Lange; Léon Perlemuter; Serge Askienazy
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-07       Impact factor: 9.236

10.  BRAF(V600E) Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer.

Authors:  S Fraser; C Go; A Aniss; S Sidhu; L Delbridge; D Learoyd; R Clifton-Bligh; L Tacon; V Tsang; B Robinson; A J Gill; M Sywak
Journal:  World J Surg       Date:  2016-07       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.